PCWA
CELU icon

Pacific Capital Wealth Advisors’s Celularity CELU Stock Holding History

Pacific Capital Wealth Advisors’s Portfolio CELU Stock Details CELU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-50
Closed -$104 – 135
2024
Q4 		$104 Hold
50
– – ﹤0.01% 385
2024
Q3 		$149 Hold
50
– – ﹤0.01% 470
2024
Q2 		$157 Hold
50
– – ﹤0.01% 497
2024
Q1 		$262 Hold
50
– – ﹤0.01% 500
2023
Q4 		$124 Buy
+50
New +$109 ﹤0.01% 334

Other funds holding CELU

CVSC
C.V. Starr & Co New York $192M AUM 35.69% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
HWM
HB Wealth Management Atlanta, Georgia $15.5B AUM 18.35% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Pacific Capital Wealth Advisors's CELU Position: Q1 2025 in Review

Pacific Capital Wealth Advisors sold out of Celularity (CELU) in Q1 2025, closing a stake of 50 shares — an estimated $104 sold.

Pacific Capital Wealth Advisors first reported a position in CELU in Q4 2023 and held it in 5 quarters. The position peaked at $262 in Q1 2024. 29 funds tracked by Wall St. Rank hold CELU as of Q1 2025.

  • Pacific Capital Wealth Advisors reported no remaining Celularity position as of Q1 2025 after selling out during the quarter.
  • Pacific Capital Wealth Advisors sold 50 Celularity shares in Q1 2025, an estimated $104.
  • Pacific Capital Wealth Advisors first reported a position in Celularity in Q4 2023 and held it in 5 quarters.
  • Pacific Capital Wealth Advisors's Celularity position peaked at $262 in Q1 2024.
  • 29 funds tracked by Wall St. Rank held Celularity as of Q1 2025.

Based on Pacific Capital Wealth Advisors's 13F filing for Q1 2025, filed 18 Apr 2025.